Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1149748

Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery


Bohac, Maja; Anticic, Marija; Draca, Natasa; Kozomara, Bojan; Dekaris, Iva; Gabric, Nikica; Patel, Sudi
Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery // Seminars in Ophthalmology, 32 (2016), 6; 725-733 doi:10.3109/08820538.2016.1170163 (međunarodna recenzija, članak, ostalo)


CROSBI ID: 1149748 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery

Autori
Bohac, Maja ; Anticic, Marija ; Draca, Natasa ; Kozomara, Bojan ; Dekaris, Iva ; Gabric, Nikica ; Patel, Sudi

Izvornik
Seminars in Ophthalmology (0882-0538) 32 (2016), 6; 725-733

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo

Ključne riječi
Endothelial cells count loss ; Veriflex ; Verisyse ; myopia ; phakic intraocular lenses.

Sažetak
Abstract Purpose: To compare refractive stability, endothelial cell count (ECC), incidence of complications, and patients' satisfaction between a rigid Verisyse (group I, n = 198) and foldable Veriflex (group II, n = 212) phakic intraocular lenses (pIOL) over 36 months postop. Materials and methods: This was a retrospective study. Patients' satisfaction and incidence of photic phenomena were evaluated at one month and one year postop. Data were analyzed to determine difference between groups for astigmatism, mean spherical equivalent (MRSE), uncorrected (UDVA) and corrected (CDVA) monocular distance visual acuity, complication rate (acute and chronic), and ECC. Differences were considered statistically significant when p < 0.05. Results: Group II cases had significantly higher UDVA, CDVA, and lower astigmatism during the entire follow-up. There was no significant difference in mean MRSE or mean ECC postoperatively. In both groups, mean ECC reduced significantly at one month postop, followed by a gradual linear decline between 1 and 36 months of 22.4 cells/mm2/annum (group I) and 13.32 cells/mm2/annum (group II). Overall complication rates were ≤ 10% with no significant inter-group differences. Group I patients reported lower incidence of halos at one month but more problems with night vision at one year compared with group II. Overall satisfaction was high and total incidence of reported photic phenomena was low. Conclusion: Both Verisyse and Veriflex pIOLs are effective in correcting myopia. The Veriflex lens demonstrated better refractive outcome ; however, subclinical inflammation observed in the Veriflex group and potential influence of inflammation on ECC loss require further investigation.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Integrativna bioetika (prirodne, tehničke, biomedicina i zdravstvo, biotehničke, društvene, humanističke znanosti), Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Specijalna bolnica Svjetlost

Profili:

Avatar Url Iva Dekaris (autor)

Avatar Url Maja Bohač (autor)

Avatar Url Nikica Gabrić (autor)

Avatar Url Nataša Drača (autor)

Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada doi

Citiraj ovu publikaciju:

Bohac, Maja; Anticic, Marija; Draca, Natasa; Kozomara, Bojan; Dekaris, Iva; Gabric, Nikica; Patel, Sudi
Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery // Seminars in Ophthalmology, 32 (2016), 6; 725-733 doi:10.3109/08820538.2016.1170163 (međunarodna recenzija, članak, ostalo)
Bohac, M., Anticic, M., Draca, N., Kozomara, B., Dekaris, I., Gabric, N. & Patel, S. (2016) Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery. Seminars in Ophthalmology, 32 (6), 725-733 doi:10.3109/08820538.2016.1170163.
@article{article, author = {Bohac, Maja and Anticic, Marija and Draca, Natasa and Kozomara, Bojan and Dekaris, Iva and Gabric, Nikica and Patel, Sudi}, year = {2016}, pages = {725-733}, DOI = {10.3109/08820538.2016.1170163}, keywords = {Endothelial cells count loss, Veriflex, Verisyse, myopia, phakic intraocular lenses.}, journal = {Seminars in Ophthalmology}, doi = {10.3109/08820538.2016.1170163}, volume = {32}, number = {6}, issn = {0882-0538}, title = {Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery}, keyword = {Endothelial cells count loss, Veriflex, Verisyse, myopia, phakic intraocular lenses.} }
@article{article, author = {Bohac, Maja and Anticic, Marija and Draca, Natasa and Kozomara, Bojan and Dekaris, Iva and Gabric, Nikica and Patel, Sudi}, year = {2016}, pages = {725-733}, DOI = {10.3109/08820538.2016.1170163}, keywords = {Endothelial cells count loss, Veriflex, Verisyse, myopia, phakic intraocular lenses.}, journal = {Seminars in Ophthalmology}, doi = {10.3109/08820538.2016.1170163}, volume = {32}, number = {6}, issn = {0882-0538}, title = {Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery}, keyword = {Endothelial cells count loss, Veriflex, Verisyse, myopia, phakic intraocular lenses.} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font